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Summary
Background:  The  prevalence  of  hepatitis  B  virus  (HBV)  among  healthcare  workers
(HCWs)  in  hospitals  in  developing  countries  is  high.  However,  the  vaccination  sta-
tus  of  these  workers  and  its  relationship  with  occupational  factors  are  not  well
documented.
Aim:  The  aim  of  this  study  was  to  evaluate  the  susceptibility  of  HCWs  to  HBV  infec-
tion  in  the  representative  Tripoli  Central  Hospital  in  Libya  and  prepare  a  practical
guideline  to  protect  HCWs  from  occupational  exposure.
Method:  In  this  cross-sectional  study,  a  questionnaire  survey  was  administered
to  2705  healthcare  workers  of  a  university  hospital  in  Tripoli.  The  questionnaire
included  vaccination  status.  Compliance  with  preventive  practices  against  HBV
infection  was  also  assessed.
Result:  The  overall  vaccination  coverage  (anti-HBs)  was  78.1%.  Furthermore,  82.6%
of  HCWs  had  received  at  least  one  dose  of  vaccine,  but  only  72%  reported  that  they
were  fully  vaccinated.  The  prevalence  of  hepatitis  B  surface  antigen  was  1.1%.  The
mean  prevalence  of  hepatitis  B  core  antibody  (anti-HBc)  was  17.3%.
Conclusion:  HCWs  at  hospitals  are  frequently  exposed  to  blood-borne  infections.
Vaccines  should  be  more  readily  available  for  Libyan  HCWs,  and  current  vaccination
programs  should  be  enforced.
©  2013  King  Saud  Bin  Abdulaziz  University  for  Health  Sciences.  Published  by  Elsevier
Ltd.  All  rights  reserved.∗ Corresponding author at: PO Box 81349, Tripoli,
Libya. Tel.: +218 914034937.
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ccupational  exposure  to  hepatitis  B virus  (HBV)
s a well-recognized  risk  for  healthcare  workers
 Sciences. Published by Elsevier Ltd. All rights reserved.
H rke
(
p
o
o
i
t
9
A
d
o
p
c
a
f
t
e
i
r
b
r
i
h
a
e
t
m
i
s
r
i
c
a
i
c
a
L
t
a
o
f
t
H
s
t
t
o
n
N
c
o
(
M
S
B
c
o
a
o
w
depatitis  B vaccination  status  among  healthcare  wo
HCWs),  and  it  is  dependent  on  the  frequency  of
ercutaneous  and  permucosal  exposure  to  blood
r body  ﬂuids  containing  blood,  which  commonly
ccurs due  to  needle  sticks  or  other  sharp  device
njuries (NSIs).  The  frequency  of  HCW  exposure
o HBV  is  inﬂuenced  by  HBV  endemicity.  Thus,
0% of  such  HBV  infections  occur  in  Asia  and
frica [1—4].  A  majority  of  countries  in  the  Mid-
le East  show  an  intermediate  or  high  endemicity
f HBV  infection,  which  clearly  poses  a  serious
ublic health  problem  in  the  region  [5].  For  such
ountries,  the  adoption  of  standard  precautions
nd HBV  vaccination  is required  to  protect  HCWs
rom infection.  In  addition,  non-speciﬁc  preven-
ive measures  (hand  cleaning,  disposable  medical
quipment,  educational  campaigns  and  proper  ster-
lization) are  critical.  Infection  depletes  human
esources,  not  only  as  a  direct  result  of  transmission
ut also  due  to  anxiety  regarding  safety,  and  poor
isk reduction  strategies  are  in  place,  particularly
n developing  countries.  Furthermore,  occupational
ealth in  the  developing  world  is  largely  neglected
nd requires  better  description  and  study  as  an
merging  concept.
Since the  hepatitis  B  vaccine  became  available,
he incidence  of  HBV  infection  and  the  associated
ortality and  morbidity  have  declined.  Therefore,
n 1997,  the  CDC  recommended  that  all  HCWs
hould be  vaccinated  against  HBV  [6].  Despite  this
ecommendation,  compliance  remains  poor  in  var-
ous healthcare  settings,  particularly  in  developing
ountries. Furthermore,  previous  studies  on  hep-
titis B  among  HCWs  in  resource-limited  settings
ndicate  variations  in  prevalence  rates  and  vac-
ination  coverage,  which  reﬂect  national  policies
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Figure  1  Participant  distribution  according  tors  247
nd  prevalence  rates.  Therefore,  the  situation  in
ibya remains  unclear.  Information  on  HBV  vaccina-
ion coverage,  the  practice  of  universal  precautions
mong HCWs,  the  assessment  of  protective  levels
f anti-HBs  among  vaccine  recipients  and  the  need
or booster  vaccination  is  scant,  but  this  informa-
ion is  needed  to  rationalize  strategies  for  better
BV infection  control.  Therefore,  the  aims  of  this
tudy were  to  evaluate  the  susceptibility  of  HCWs
o HBV  infection  in  the  representative  Tripoli  Cen-
ral Hospital  in  Libya  and  determine  the  compliance
f HCWs  involved  in  direct  patient  care  (physicians,
urses, and  technicians)  regarding  HBV  vaccination.
ationally appropriate  policy  decisions  on  the  vac-
ination of  health  workers  in  Libya  should  be  based
n information  on  hepatitis  B  exposure  in  this  group
Fig.  1).
ethods
tudy design and setting
etween  28  February  and  28  December  2011,  we
onducted  a cross-sectional  study  on  the  HCWs
f Tripoli  Central  Hospital,  a  640-bed  university-
fﬁliated tertiary  hospital  located  in  the  Center
f Tripoli,  Libya.  A  survey  for  anti-HBs  and  HBsAg
as performed  on  2705  HCWs  across  different
epartments in  the  hospital.  All  HCWs  in  these
epartments were  invited  to  participate.  There  was
o speciﬁc  vaccination  campaign  in  our  hospital
uring the  study  period.  We  deﬁned  two  categories
f HCWs:  HCWs  in  direct  contact  with  patients
Administrave Female Ma le
HBs Ag (-)/ an -HBs ( -)
 gender,  occupation  and  anti-HBs  results.
v
t
v
t
i
o
r
t
f
S
A
S
v
S
s
t
R
P
T
1
a
m
1
w
t
l
c
(
n
T
h
p
c
a
v
c
c
t
A
T
H
l248  
(physicians,  nurses,  and  medical  and  nursing  assis-
tants) and  HCWs  not  in  direct  contact  with  patients
(secretaries  and  administrative  staff).  The  clinical
protocol  was  reviewed  and  approved  by  the  Board
for Research  Involving  Human  Subjects.
Data collection and variable deﬁnitions
A  standardized  questionnaire  designed  speciﬁcally
for the  study  was  used  to  collect  information  con-
cerning  demographic  characteristics  (sex,  age,  and
speciﬁc occupation)  and  hepatitis  B  vaccination
status, and  if  applicable,  reasons  for  the  lack  of
vaccination  were  collected.  Data  regarding  vac-
cination  coverage  were  recorded  on  the  basis  of
self-report.  The  questionnaires  were  completed
by clinical  research  nurses.  The  questionnaire  was
pilot tested  and  reviewed  for  clarity  before  use.
Laboratory testing
Venous  blood  samples  were  collected  from  every
participant  in  accordance  with  universal  pre-
cautions. Specimens  were  delinked  from  the
participants’ identity  to  ensure  conﬁdentiality  and
blinding of  the  laboratory  staff.  Serologic  speci-
mens from  participants  were  tested  for  anti-HBs
(Architect; Abbott  Laboratories)  using  an  ELISA.
The lower  limit  of  detection  of  this  assay  was
anti-HBs ≥ 2  mIU/ml.  Antibodies  against  hepatitis  B
core antigen  (anti-HBc)  were  evaluated  (Corzyme;
Abbott Laboratories),  and  positive  specimens  were
subsequently  tested  for  hepatitis  B  surface  antigen
(HBsAg)  (Auszyme  Monoclonal;  Abbott  Laborato-
ries) and  hepatitis  B  core  antigen  (HBcAg)  (Auszyme
Monoclonal;  Abbott  Laboratories).
Deﬁnitions
An  HBV  infection  was  deﬁned  as  a  positive  anti-HBc
or HBsAg  result,  as  described  elsewhere.  A  response
or sero-protection  was  deﬁned  as  an  antibody  titer
≥10 IU/l  as  the  cut-off  level,  which  correlates  with
protection  against  both  acute  disease  and  chronic
hepatitis  B  infection,  and  sero-negative  was  deﬁned
as a  concentration  less  than  10  mIU/ml,  as  indi-
cated  in  the  protocol  of  the  analysis  kit  [7]. We
deﬁned HCWs  as  completely  vaccinated  if  they  had
followed  the  Centers  for  Disease  Control  and  Pre-
vention  (CDC)  vaccination  criteria  and  incompletely
vaccinated if  they  had  received  at  least  one  dose  of
vaccination  but  did  not  follow  the  CDC  criteria  for
complete  vaccination  [8].
Healthcare  workers  who  were  negative  for  both
HBs and  anti-HBs  were  advised  to  receive  the  hep-
atitis B  vaccine  at  months  0,  1,  and  6.  The  HBV
g
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accine  was  provided  by  the  hospital  free  of  cost
o all  the  HCWs.  The  vaccine  schedule  was  pro-
ided to  the  HCWs,  and  the  vaccine  was  issued  by
he pharmacy  department  and  administered  by  the
njection room  staff  in  the  outpatient  department
f the  Infectious  Diseases  Department.  Those  who
eceived vaccination  were  reminded  to  return  two
o three  months  after  the  completion  of  vaccination
or anti-HBs  testing.
tatistical analysis
ll  statistical  analyses  were  performed  using  the
tatistical  Package  for  the  Social  Sciences  (SPSS),
ersion  17.0  for  Windows  (SPSS,  Inc.  Chicago,  IL).
tatistical  analyses  were  performed  using  the  chi-
quare test.  The  statistical  signiﬁcance  was  set  at
he P =  0.05  level.
esults
opulation characteristics
his  study  included  2705  employees  ranging  from
7 to  74  years  of  age  (mean:  35.5  years  [SD  =  9.7]),
nd the  majority  were  female  (60.1%).  Approxi-
ately 31.2%  were  nurses,  25.2%  were  physicians,
2% were  paramedics,  and  29%  were  administrative
orkers. The  paramedics  belonged  to  the  special-
ies of  physiotherapy,  operating  room,  imaging,  and
aboratory (Table  1).
Of the  HCWs  vaccinated,  82.6%  (2234/2705)
laimed to  have  received  at least  one  dose
Engerix GlaxoSmithKline©-20  g)  (partially  vacci-
ated),  and  72%  (1950/2705)  received  three  doses.
he majority  (65%)  of  the  partly  vaccinated  group
ad not  received  a hepatitis  B  vaccine  within  the
ast 5—10  years  or  could  only  recollect  that  a  vac-
ine had  not  been  received  recently.  Four  hundred
nd seventy-one  subjects  (17.4%)  had  not  been
accinated  with  hepatitis  B  vaccine.  Vaccination
overage was  the  highest  among  paramedics  in
omparison  with  other  job  categories,  as  shown  in
he graph  and  Table  1.
nti-HBs antibody measurements
he  anti-HBs  titer  was  determined  for  2704
CWs. The  anti-HBs  antibody  concentrations  were
ess than  10  mIU/ml  in  591  employees  (21.8%),
reater than  or  equal  to  10  mIU/ml  and  less  than
00 mIU/ml  in  487  employees  (18%),  and  greater
han or  equal  to  100  mIU/ml  in  1626  employees
60.2%). Anti-HBs  levels  of 1000  mIU/ml  or  greater
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Table  1  Participant  distribution  according  to  anti-HBs  results.
HBsAg  (−)/anti-HBs  (+)  HBsAg  (−)/anti-HBs  (−)  Total  P  value
Gender
•  Female  1263  (77.7%)  363  (22.3%)  1626  (60.1%)  0.755
•  Male  850  (78.8%)  228  (21.2%)  1078  (39.9%)
Occupation
•  Doctors 531  (77.4%) 155  (22.6%) 686  (25.4%)  0.003
•  Nurses 691  (76.6%) 211  (23.4%) 902  (33.3%)
•  Paramedics 263  (81.9%) 58  (18.1%) 321(11.9%)
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t•  Administrative  628  (80%)  
ere  not  quantiﬁed  further.  HCWs  who  had  a poor
mmune response  (anti-HBs  < 10  IU/l)  did  not  differ
igniﬁcantly  in  terms  of  age  or  sex  from  those  who
ad a  good  immune  response  (anti-HBs  ≥10  IU/l).
Table  2  shows  the  sero-prevalence  of  biological
arkers and  the  number  of  vaccine  doses  recorded
n registers  for  2704  healthcare  workers.  Two  hun-
red and  forty-three  HCWs  could  not  recall  a  history
f hepatitis  B  infection.
Of  the  2674  subjects  who  were  HBsAg  nega-
ive, IgG  anti-HBc  testing  was  performed  in  750
ubjects.  A  total  of  130  (17.3%)  subjects  were  posi-
ive, and  hepatitis  B  antibody  was  observed,  which
ight indicate  evidence  of  past  exposure  to  hep-
titis  B infection.  Anti-HBc  antibody  positivity  was
he lowest  in  doctors  (P  =  0.027)  and  the  highest  in
ubordinate  and  casual  staff  (P  =  0.042).
iscussion
his  study  shows  that  21.8%  of  the  studied  HCWs
ould have  contracted  HBV  after  a  needle  stick
njury involving  an  HBV  carrier’s  blood.  The  preva-
ence  of  hepatitis  B  virus  (HBV)  carriage  in  the
iddle East  has  been  reported  to  vary  from  5  to
8% [9—11].  In  some  regions,  however,  rates  of
ess than  5%  have  been  reported  [12]. To  decrease
he prevalence  of  HBV  infection,  many  countries
ave introduced  hepatitis  B  vaccination  through
s
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Table  2  Sero-prevalence  of  biological  markers  and  numbe
Serological  markers  Number  of  vaccine  do
0  dose  1  dose  
N  (%)  N  (%)  
Naive  and  no  Ab  response
(anti-HBs  negative)
116  (19.6%)  58  (9.8%
Immunized  with  an  Ab  response
(anti-HBs  positive)
226  (12.1%)  178  (9.57  (20%)  795  (29.4%)
heir  expanded  program  on  immunization  (EPI).  In
ibya, hepatitis  B  vaccination  was  added  to  the
PI in  1993.  Data  from  a national  population-based
ero-epidemiological  survey  showed  that  the  over-
ll prevalence  of  HBV  was  2.2%  [13].  To  the  best
f our  knowledge,  our  study  is  the  ﬁrst  to  ana-
yze trends  in  the  immunological  status  of  hepatitis
 in  a population  of  healthcare  workers  in  a  ter-
iary hospital  in  Tripoli  City,  Libya.  Assessing  HBV
accination  coverage  in  the  healthcare  setting  is
eeded to  evaluate  the  proportion  susceptible  to
BV infection  [14].  In  this  study,  78.2%  of  the
CWs were  vaccinated,  but  21.8%  were  not.  The
on-vaccinated  HCWs  most  often  included  adminis-
rative workers  and  hospital  attendants.  We  chose  a
hreshold of  sero-positivity  of  10  mIU/ml,  as  recom-
ended  by  the  United  States  Advisory  Committee
n Immunization  Practices  and  the  World  Health
rganization [15], instead  of  100  mIU/ml,  which  is
sed as  the  threshold  in  several  European  countries
16].
At the  study  hospital,  HBV  vaccination  is  not
andatory and  is  only  recommended  (and  offered
ree) for  HCWs.  Therefore,  it  is  the  employee’s
esponsibility  to  continue  the  vaccination  sched-
le. The  HBV  vaccination  rates  among  HCWs  in
he Middle  East  and  other  countries  with  low
ocioeconomic status  have  been  reported  to  be
nsatisfactory  [17]. Reports  from  India  [18,19],
akistan [20,21], Egypt  [22], Brazil  [23]  and  Nigeria
24,25]  indicate  that  only  16—60%  of  HCWs  have
r  of  vaccine  doses.
ses  reported  P  value
2  doses  3  doses  Total
N  (%)  N  (%)  N  (%)
)  63  (10.6%)  354  (59.9%)  591  0.001
%)  135  (7.21%)  1331  (71.2%)  1870  0.0023
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received  complete  HBV  immunization.  In  these
countries, paramedics  were  more  often  unaware
of HBV/HCV  transmission  and  received  HBV  vac-
cination  less  often  than  doctors.  The  practice  of
universal  precautions,  such  as  safe  needle  disposal,
wearing  gloves  during  phlebotomy  and  using  gog-
gles, was  also  suboptimal  among  HCWs  in  these
countries [23,26]. Therefore,  it  is  important  to
realize that  in  healthcare  settings,  pre-exposure
vaccination  programs  are  not  only  important  for
the safety  of  HCWs  but  have  also  proven  to  be  cost
effective  relative  to  post-exposure  prophylaxis  with
hyperimmunoglobulin.
The main  strength  of  this  study  is  that  it
allowed us  to  include  all  occupational  categories  of
HCWs. Furthermore,  the  population  was  randomly
selected. The  participation  rate  was  of  particu-
lar interest  because  the  study  was  performed  in
a developing  country  where  inhabitants  are  not
accustomed  to  participating  in  epidemiological  and
research studies  [12]. All  participants  received
their serological  testing  results  with  a  medical
interpretation.  However,  this  study  has  potential
limitations. HCW  education  and  income  levels  as
well as  length  of  practice  were  not  evaluated,  and
these characteristics  may  inﬂuence  vaccination  sta-
tus [27,28].
While  a  national  Libyan  policy  has  not  yet  been
implemented by  the  Department  of  Health,  it  is
encouraging  to  observe  that  with  72%  of  HCWs
reporting that  they  received  3  vaccine  doses,  the
HBV vaccination  coverage  of  the  HCWs  in  this  study
was much  higher  than  the  15.8%  of  HCWs  in  other
developing  countries  [22].
In conclusion,  we  believe  that  the  results  of  our
study are  directly  relevant  to  healthcare  workers.
There is  a  need  to  strictly  implement  the  policy  of
hepatitis  B  immunization  in  every  healthcare  set-
ting as  recommended  by  the  CDC.
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